These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28319736)

  • 1. Structural variants in SNCA gene and the implication to synucleinopathies.
    Chiba-Falek O
    Curr Opin Genet Dev; 2017 Jun; 44():110-116. PubMed ID: 28319736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of SNCA gene expression: implications to synucleinopathies.
    Tagliafierro L; Chiba-Falek O
    Neurogenetics; 2016 Jul; 17(3):145-57. PubMed ID: 26948950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of genetics in the etiology of synucleinopathies].
    Elcoroaristizabal Martín X; Gómez Busto F; González Fernández MC; de Pancorbo MM
    Rev Esp Geriatr Gerontol; 2011 Oct; 46 Suppl 1():3-11. PubMed ID: 22152908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic investigation of alpha-synuclein multiplication and parkinsonism.
    Ross OA; Braithwaite AT; Skipper LM; Kachergus J; Hulihan MM; Middleton FA; Nishioka K; Fuchs J; Gasser T; Maraganore DM; Adler CH; Larvor L; Chartier-Harlin MC; Nilsson C; Langston JW; Gwinn K; Hattori N; Farrer MJ
    Ann Neurol; 2008 Jun; 63(6):743-50. PubMed ID: 18571778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Synucleinopathies.
    Nussbaum RL
    Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 28213435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward deciphering the mechanistic role of variations in the Rep1 repeat site in the transcription regulation of SNCA gene.
    Afek A; Tagliafierro L; Glenn OC; Lukatsky DB; Gordan R; Chiba-Falek O
    Neurogenetics; 2018 Aug; 19(3):135-144. PubMed ID: 29730780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synucleinopathies: clinical and pathological implications.
    Galvin JE; Lee VM; Trojanowski JQ
    Arch Neurol; 2001 Feb; 58(2):186-90. PubMed ID: 11176955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.
    Cronin KD; Ge D; Manninger P; Linnertz C; Rossoshek A; Orrison BM; Bernard DJ; El-Agnaf OM; Schlossmacher MG; Nussbaum RL; Chiba-Falek O
    Hum Mol Genet; 2009 Sep; 18(17):3274-85. PubMed ID: 19498036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants and animal models in SNCA and Parkinson disease.
    Deng H; Yuan L
    Ageing Res Rev; 2014 May; 15():161-76. PubMed ID: 24768741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication.
    Siddiqui IJ; Pervaiz N; Abbasi AA
    Sci Rep; 2016 Apr; 6():24475. PubMed ID: 27080380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability in SNCA and Parkinson's disease.
    Pihlstrøm L; Toft M
    Neurogenetics; 2011 Nov; 12(4):283-93. PubMed ID: 21800132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.
    Soldner F; Stelzer Y; Shivalila CS; Abraham BJ; Latourelle JC; Barrasa MI; Goldmann J; Myers RH; Young RA; Jaenisch R
    Nature; 2016 May; 533(7601):95-9. PubMed ID: 27096366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation.
    Fonseca-Ornelas L; Eisbach SE; Paulat M; Giller K; Fernández CO; Outeiro TF; Becker S; Zweckstetter M
    Nat Commun; 2014 Dec; 5():5857. PubMed ID: 25524885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SNCA rs356219 AND rs356165 VARIANTS ARE ASSOCIATED WITH PARKINSON'S DISEASE AND INCREASED ALPHA-SYNUCLEIN GENE EXPRESSION IN THE CD45(+)-BLOOD CELLS].
    Emelyanov AK; Andoskin PA; Miliukhina IV; Timofeeva AA; Yakimovskii AF; Senkevich KA; Nikolaev MA; Pchelina SN
    Tsitologiia; 2016; 58(2):99-104. PubMed ID: 27228655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between alpha-synuclein and Parkinson's disease].
    Nishioka K; Hattori N
    Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.